Search for: "Anda Pharmaceuticals, Inc"
Results 101 - 120
of 605
Sorted by Relevance
|
Sort by Date
29 Jun 2014, 9:21 pm
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
14 Jun 2015, 8:59 pm
Janssen Pharmaceuticals Inc. v. [read post]
28 Dec 2014, 9:49 pm
Par Pharmaceutical Inc. 1:14-cv-01494; filed December 18 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Par Pharmaceutical Inc. [read post]
3 Jan 2016, 9:33 pm
Spectrum Pharmaceuticals, Inc. et al. v. [read post]
8 Oct 2016, 3:25 am
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
25 Feb 2013, 11:00 pm
Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court’s finding that two Orange Book-listed patents for Cephalon’s FENTORA® product were invalid, but affirmed the district court’s finding that Watson’s ANDA product would not... [read post]
27 Jan 2014, 9:47 am
("Par Pharmaceutical Companies") and Par Pharmaceutical, Inc. [read post]
25 Nov 2014, 9:55 pm
Par Pharmaceutical, Inc. v. [read post]
7 May 2013, 12:27 pm
Chief Judge Gregory Sleet recently denied a generic pharmaceutical company’s request for leave to move for summary judgment before a Rule 16(b) conference in an ANDA case. [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
6 Feb 2011, 9:34 pm
• Defendants: Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
4 Aug 2013, 9:53 pm
• Defendant: Sun Pharma Global FZE; Sun Pharmaceutical Industries, LTD.; Sun Pharmaceutical Industries, Inc. [read post]
28 Jun 2015, 10:25 pm
• Defendants: Macleods Pharmaceuticals Ltd.; Macleods Pharma USA, Inc. [read post]
18 Dec 2023, 9:07 pm
Mylan Pharmaceuticals Inc. [read post]
17 Jan 2016, 8:19 pm
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
29 Sep 2013, 9:11 pm
Apotex Inc. et al. 1:13-cv-01613; filed September 25, 2013 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Apotex Inc.; Apotex Corp. [read post]
9 May 2012, 8:57 pm
Mylan Pharmaceuticals Inc. [read post]
17 Mar 2016, 12:12 pm
The allegations of infringement have been directed at Defendants Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania and its parent company Teva Pharmaceutical Industries Ltd. of Israel. [read post]
5 Aug 2012, 7:54 pm
Sunovion Pharmaceuticals Inc. v. [read post]
9 Sep 2013, 9:27 pm
Akorn, Inc. 1:13-cv-06080; filed August 28, 2013 in the Southern District of New York • Plaintiffs: Senju Pharmaceutical Co., Ltd.; Bausch & Lomb, Inc.; Bausch & Lomb Pharma Holdings Corp. [read post]
